share_log
Reuters ·  Mar 26 21:01
Soleno Therapeutics Inc - FDA Approves Soleno's Vykat Xr for Hyperphagia in Prader-Willi Syndrome - SEC Filing
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 249
Write a comment